Zarontin

Zarontin is a brand name of ethosuximide, approved by the FDA in the following formulation(s):

ZARONTIN (ethosuximide - capsule; oral)

• 
  Manufacturer: PARKE DAVIS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 250MG ^[RLD][AB]

Has a generic version of Zarontin been approved?

Yes. The following products are equivalent to Zarontin:

ethosuximide capsule; oral

• 
  Manufacturer: BANNER PHARMACAPS
  
  Approval date: October 28, 2002
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: VERSAPHARM
  
  Approval date: May 28, 2008
  
  Strength(s): 250MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zarontin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zarontin.

See also...

• Zarontin Consumer Information (Wolters Kluwer)
• Zarontin Solution Consumer Information (Wolters Kluwer)
• Zarontin Consumer Information (Cerner Multum)
• Zarontin Advanced Consumer Information (Micromedex)
• Zarontin AHFS DI Monographs (ASHP)
• Ethosuximide Consumer Information (Wolters Kluwer)
• Ethosuximide Solution Consumer Information (Wolters Kluwer)
• Ethosuximide Consumer Information (Cerner Multum)
• Ethosuximide Advanced Consumer Information (Micromedex)
• Ethosuximide AHFS DI Monographs (ASHP)